Status:
COMPLETED
taVNS on Pupillary Response and Perceptual Learning
Lead Sponsor:
NYU Langone Health
Conditions:
Pupillary Response
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
This study has two parts. The study team will evaluate transcutaneous auricular vagal nerve stimulation (taVNS) and two sham settings during a passive task while measuring pupillary response. Second, ...
Eligibility Criteria
Inclusion
- Healthy individuals 18 to 65
- Normal audiometric testing
Exclusion
- Co-morbidities including cardiomyopathies, arrhythmias
- Implantable devices including vagal stimulators, pacemakers
- Presence of metallic implants
- Pregnancy
Key Trial Info
Start Date :
May 18 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 9 2025
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT05386563
Start Date
May 18 2022
End Date
July 9 2025
Last Update
December 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NYU Langone Health - Bellevue Hospital
New York, New York, United States, 10016